CLB

19.54

0.05% 0.010

Handel nachbörslich: 19.54

Core Laboratories Inc (CLB)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$19.53

Offen:

$19.88

24-Stunden-Volumen:

122.05K

Relative Volume:

0.39

Marktkapitalisierung:

$917.41M

Einnahmen:

$502.79M

Nettoeinkommen (Verlust:

$23.71M

KGV:

39.08

EPS:

0.5

Netto-Cashflow:

$6.35M

1W Leistung:

-7.87%

1M Leistung:

+4.77%

6M Leistung:

+8.31%

1J Leistung:

+6.89%

1-Tages-Spanne:

$19.53

$20.00

1-Wochen-Bereich:

$19.36

$21.57

52-Wochen-Spanne:

$13.82

$25.13

Core Laboratories Inc Stock (CLB) Company Profile

Firmenname

Core Laboratories Inc

Sektor

Energy (247)

Branche

Oil & Gas Equipment & Services (49)

Telefon

713-328-2673

Adresse

6316 WINDFERN ROAD, HOUSTON

Mitarbeiter

3,600

Twitter

@corelabcompany

Nächster Verdiensttermin

2024-10-23

Neueste SEC-Einreichungen

CLB's Discussions on Twitter

Vergleichen Sie CLB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLB	19.54	917.41M	502.79M	23.71M	6.35M	0.50
SLB	43.49	61.37B	36.00B	4.48B	5.15B	2.89
BKR	43.07	42.82B	27.30B	2.24B	1.79B	1.66
HAL	30.45	26.75B	23.07B	2.55B	2.40B	2.91
TS	37.50	21.49B	13.42B	2.74B	3.27B	6.10
FTI	28.51	12.13B	8.79B	671.20M	856.30M	-0.0791

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-06-30	Herabstufung	Citigroup	Neutral → Sell
2023-04-18	Herabstufung	BofA Securities	Neutral → Underperform
2023-01-09	Hochstufung	BofA Securities	Underperform → Neutral
2022-10-07	Hochstufung	Citigroup	Sell → Neutral
2022-09-26	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-04-18	Herabstufung	Piper Sandler	Neutral → Underweight
2021-10-18	Herabstufung	BofA Securities	Neutral → Underperform
2021-07-09	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-06-14	Herabstufung	Citigroup	Neutral → Sell
2020-12-18	Herabstufung	JP Morgan	Neutral → Underweight
2020-11-11	Bestätigt	Cowen	Market Perform
2020-10-13	Hochstufung	BofA Securities	Underperform → Neutral
2020-09-29	Hochstufung	ABN Amro	Sell → Hold
2020-07-16	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2020-04-13	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2020-03-09	Herabstufung	BofA/Merrill	Buy → Underperform
2020-03-09	Herabstufung	Evercore ISI	Outperform → In-line
2020-01-31	Bestätigt	Cowen	Market Perform
2020-01-30	Fortgesetzt	Johnson Rice	Buy
2020-01-14	Eingeleitet	Bernstein	Mkt Perform
2020-01-02	Herabstufung	Stifel	Buy → Hold
2019-12-31	Bestätigt	Cowen	Market Perform
2019-07-10	Hochstufung	BofA/Merrill	Neutral → Buy
2019-02-25	Hochstufung	Tudor Pickering	Hold → Buy
2018-12-19	Herabstufung	Credit Suisse	Outperform → Neutral
2018-12-11	Herabstufung	JP Morgan	Overweight → Neutral
2018-11-16	Hochstufung	Guggenheim	Neutral → Buy
2018-11-01	Hochstufung	ABN Amro	Sell → Buy
2018-10-29	Bestätigt	Cowen	Market Perform

Alle ansehen

Core Laboratories Inc Aktie (CLB) Neueste Nachrichten

Nov 16, 2024

Royce & Associates LP Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Nov 16, 2024

Nov 15, 2024

US Bancorp DE Sells 572 Shares of Core Laboratories Inc. (NYSE:CLB) - Defense World

Nov 15, 2024

Van ECK Associates Corp Has $7.13 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Nov 08, 2024

Nov 07, 2024

Is the Options Market Predicting a Spike in CORE LABS INC (CLB) Stock? - Yahoo Finance

Nov 07, 2024

Core Laboratories (NYSE:CLB) Upgraded by StockNews.com to "Hold" Rating - MarketBeat

Nov 07, 2024

Core Laboratories (NYSE:CLB) Upgraded to Hold at StockNews.com - Defense World

Nov 07, 2024

Nov 04, 2024

Citigroup Issues Pessimistic Forecast for Core Laboratories (NYSE:CLB) Stock Price - Defense World

Nov 04, 2024

Nov 03, 2024

Core Laboratories Inc. (NYSE:CLB) Receives $18.00 Average Target Price from Analysts - Defense World

Nov 03, 2024

Nov 02, 2024

Core Laboratories Inc. (NYSE:CLB) Holdings Cut by Creative Planning - Defense World

Nov 02, 2024

Oct 30, 2024

StockNews.com Upgrades Core Laboratories (NYSE:CLB) to Hold - Defense World

Oct 30, 2024

Oct 28, 2024

Core Laboratories (NYSE:CLB) Upgraded by StockNews.com to Hold - MarketBeat

Oct 28, 2024

Core Laboratories (NYSE:CLB) Shares Gap DownTime to Sell? - MarketBeat

Oct 28, 2024

Oct 27, 2024

Core Laboratories Inc. (NYSE:CLB) Stake Reduced by Boston Trust Walden Corp - MarketBeat

Oct 27, 2024

Oct 25, 2024

Core Laboratories N.V. (NYSE:CLB) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 25, 2024

Core Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Oct 25, 2024

Core Laboratories' Q3 Earnings and Sales Beat Estimates - MSN

Oct 25, 2024